Suzhou Ailong Technology Competitors and Similar CompaniesClear all

Suzhou Ailong Technology's competitors and similar companies include Enzyre, Bactiguard, Omini and Cardionomic.

	Suzhou Ailong Technology Suzhou Ailong Technology (苏州艾隆科技股份有限公司) is a company that is engaged in the intelligent management of medical supplies in the pharmacy, wards, and logistics sectors.	Enzyre Enzyre is a diagnostic technology company.	Bactiguard Bactiguard, a medtech company, develops and provides infection prevention solutions.	Omini Omini is a company developing point-of-care lab-on-chip devices for immediate blood tests.	Cardionomic Cardionomic is a company that provides cardiac treatments intended to be used for treating acute decompensated heart failure.
Founding Date	Founding Date 2006	Founding Date 2016	Founding Date 2005	Founding Date 2019	Founding Date 2011
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare healthtech machinery medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech
Locations	Locations Su Zhou Shi, CN HQ	Locations Nijmegen, NL HQ	Locations Botkyrka, SE HQ	Locations HQ	Locations Saint Paul, US HQ
Employees	Employees 700	Employees 18	Employees 147	Employees 526% increase	Employees 4
Valuation ($)	Valuation ($) 167.1 m	Valuation ($) N/A	Valuation ($) 139.7 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥404.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) kr215.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥224.3m (FY, 2025)	Cost of goods N/A	Cost of goods kr31.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥210.1m (FY, 2025)	Gross profit N/A	Gross profit kr194.3m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ¥19.8m (FY, 2025)	Net income N/A	Net income (kr7.8m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 14.9m	Total funding raised N/A	Total funding raised $ 44.8m